5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors

5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeico...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 183; no. 4; pp. 1633 - 1643
Main Authors Chavis, C, Vachier, I, Chanez, P, Bousquet, J, Godard, P
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 01.04.1996
Subjects
Online AccessGet full text
ISSN0022-1007
1540-9538
DOI10.1084/jem.183.4.1633

Cover

Abstract 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.
AbstractList 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.
5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.
5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S),15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-HETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE. Moreover, the total amount of LXs biosynthesized by PMN from asthmatics was twofold higher than that biosynthesized by PMN from controls. In the absence of exogenous 15(S)-HETE, PMN from asthmatics were able to produce 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.
Author Vachier, I
Chanez, P
Godard, P
Chavis, C
Bousquet, J
Author_xml – sequence: 1
  givenname: C
  surname: Chavis
  fullname: Chavis, C
– sequence: 2
  givenname: I
  surname: Vachier
  fullname: Vachier, I
– sequence: 3
  givenname: P
  surname: Chanez
  fullname: Chanez, P
– sequence: 4
  givenname: J
  surname: Bousquet
  fullname: Bousquet, J
– sequence: 5
  givenname: P
  surname: Godard
  fullname: Godard, P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8666921$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQtVBR2Rau3JB8QiCRYDuJ1-4BCVV8SZU4AGfLsSddV4kd7AQ2P4t_iLNdKkBCXGyN583zzLx3hk588IDQY0pKSkT98gaGkoqqrEvKq-oe2tCmJoVsKnGCNoQwVlBCtg_QWUo3hNC6bvgpOhWcc8noBv1onn16_oKuZ2HdbrEx7BdwJiQ9wRQ1-OAM1sZZrL3FvRvD3nl8DR6inlzwOEe7edAej6FfhhDHXfCz6UFHbKDv0wW2s-5xGsG4zhk3LTh0uCkOVEsm0gnwFL7raBMGb0N-CnM6fAf7X9EYwcwxhZgeovud7hM8Ot7n6MvbN58v3xdXH999uHx9VZhasKnQTLSmbrdNBwK4oTYHvOsE2FaCraqKNBVhXLbdtpVNbTKQtQyYNEZYyVl1jl7d8o5zO4A14PM6ejVGN-i4qKCd-jPj3U5dh2-KUckaSjLB0yNBDF9nSJMaXFpXoj3kkdRWUCKJkP8F0oZzIcXK-OT3lu56OaqZ8-Vt3sSQUoTuDkGJWt2isltUdouq1eqWXFD_VZD1OciaJ3L9v8p-AnIByq8
CitedBy_id crossref_primary_10_1096_fj_00_0508hyp
crossref_primary_10_1007_s11745_005_1379_z
crossref_primary_10_1152_ajplung_00018_2008
crossref_primary_10_1152_ajprenal_00224_2003
crossref_primary_10_1016_j_mam_2017_04_006
crossref_primary_10_1016_S0022_3565_24_37857_7
crossref_primary_10_1038_s41419_020_02846_7
crossref_primary_10_1007_s00109_017_1542_4
crossref_primary_10_1016_j_bbalip_2021_159093
crossref_primary_10_1016_j_jaci_2012_07_048
crossref_primary_10_3389_froh_2023_1288722
crossref_primary_10_3389_fphar_2022_838782
crossref_primary_10_1067_mai_2001_113868
crossref_primary_10_1021_bi992551b
crossref_primary_10_1164_rccm_200201_053OC
crossref_primary_10_1016_j_rmr_2011_12_009
crossref_primary_10_5936_csbj_201303018
crossref_primary_10_3389_fimmu_2022_915261
crossref_primary_10_1016_S0090_6980_97_00001_4
crossref_primary_10_4049_jimmunol_170_12_6266
crossref_primary_10_1111_all_15103
crossref_primary_10_1074_jbc_272_11_6972
crossref_primary_10_1517_14712598_2016_1118458
crossref_primary_10_1183_09031936_00106013
crossref_primary_10_1016_S0006_2952_98_00086_0
crossref_primary_10_1096_fsb2fj000508hyp
crossref_primary_10_1016_S0090_6980_02_00047_3
crossref_primary_10_1021_acs_biochem_5b01339
crossref_primary_10_1073_pnas_96_14_8247
crossref_primary_10_1006_bbrc_2001_6155
crossref_primary_10_1084_jem_189_12_1923
crossref_primary_10_1096_fj_01_0576fje
crossref_primary_10_1096_fj_15_275487
crossref_primary_10_1515_CCLM_1999_052
crossref_primary_10_1021_acs_biochem_0c00622
crossref_primary_10_4049_jimmunol_169_12_7063
crossref_primary_10_1016_j_bbalip_2020_158702
crossref_primary_10_1186_s13052_024_01654_5
crossref_primary_10_4049_jimmunol_1500610
crossref_primary_10_1016_j_plefa_2005_05_017
crossref_primary_10_1006_abio_1999_4113
crossref_primary_10_1074_jbc_M210294200
crossref_primary_10_1371_journal_pone_0112816
crossref_primary_10_1016_j_prostaglandins_2023_106726
crossref_primary_10_1155_2015_781087
crossref_primary_10_1096_fasebj_12_6_487
crossref_primary_10_3389_fimmu_2020_01307
crossref_primary_10_1111_j_1398_9995_2004_00617_x
crossref_primary_10_1074_jbc_273_49_32535
crossref_primary_10_1089_wound_2014_0589
crossref_primary_10_1016_j_bcp_2007_04_005
crossref_primary_10_1016_j_jaci_2012_01_073
crossref_primary_10_1016_j_bbalip_2018_10_003
crossref_primary_10_1016_j_plefa_2005_05_002
crossref_primary_10_1038_89759
crossref_primary_10_1067_mai_2000_105122
crossref_primary_10_1177_154405910308200202
crossref_primary_10_1016_j_biopha_2007_02_016
crossref_primary_10_3390_cancers6031500
crossref_primary_10_1016_j_prostaglandins_2021_106610
crossref_primary_10_1016_j_tetlet_2010_01_109
crossref_primary_10_1177_154411130301400102
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
5PM
DOI 10.1084/jem.183.4.1633
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
AIDS and Cancer Research Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1540-9538
EndPage 1643
ExternalDocumentID PMC2192510
8666921
10_1084_jem_183_4_1633
Genre Journal Article
GroupedDBID ---
-~X
.55
.GJ
0VX
18M
29K
2WC
36B
3O-
53G
5GY
5RE
5VS
9M8
AAYXX
ABOCM
ABZEH
ACGFO
ACNCT
ACPRK
ADBBV
AENEX
AFFNX
AFOSN
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C45
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EMB
F5P
F9R
GX1
H13
HYE
H~9
IH2
K-O
KQ8
L7B
MVM
N9A
O5R
O5S
OK1
P2P
P6G
R.V
RHI
SJN
TR2
TRP
UHB
VH1
W8F
WOQ
X7M
ZGI
CGR
CUY
CVF
ECM
EIF
FRP
NPM
RHF
RPM
VXZ
7T5
H94
7X8
5PM
ID FETCH-LOGICAL-c482t-a28bc4b75fe8e6c1dc4b6ff8edb9ed3330530269bf7b954c75f2b2e29cc8d9623
ISSN 0022-1007
IngestDate Thu Aug 21 18:10:16 EDT 2025
Fri Sep 05 04:48:10 EDT 2025
Thu Sep 04 19:38:42 EDT 2025
Wed Feb 19 02:36:43 EST 2025
Tue Jul 01 03:29:44 EDT 2025
Thu Apr 24 22:52:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c482t-a28bc4b75fe8e6c1dc4b6ff8edb9ed3330530269bf7b954c75f2b2e29cc8d9623
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC2192510
PMID 8666921
PQID 15668980
PQPubID 23462
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2192510
proquest_miscellaneous_78109089
proquest_miscellaneous_15668980
pubmed_primary_8666921
crossref_primary_10_1084_jem_183_4_1633
crossref_citationtrail_10_1084_jem_183_4_1633
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1996-04-01
PublicationDateYYYYMMDD 1996-04-01
PublicationDate_xml – month: 04
  year: 1996
  text: 1996-04-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of experimental medicine
PublicationTitleAlternate J Exp Med
PublicationYear 1996
Publisher The Rockefeller University Press
Publisher_xml – name: The Rockefeller University Press
SSID ssj0014456
Score 1.769222
Snippet 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1633
SubjectTerms Arachidonate 5-Lipoxygenase - metabolism
Arachidonic Acids - biosynthesis
Asthma - metabolism
Calcimycin - pharmacology
Chromatography, High Pressure Liquid
Female
Humans
Hydroxyeicosatetraenoic Acids - biosynthesis
Hydroxyeicosatetraenoic Acids - metabolism
Hydroxyeicosatetraenoic Acids - pharmacology
Male
Models, Biological
Neutrophil Activation - drug effects
Neutrophil Activation - physiology
Substrate Specificity
Title 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors
URI https://www.ncbi.nlm.nih.gov/pubmed/8666921
https://www.proquest.com/docview/15668980
https://www.proquest.com/docview/78109089
https://pubmed.ncbi.nlm.nih.gov/PMC2192510
Volume 183
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEGgvE7eJcvUDEqCSLnGcxOENTaANNF62ob1FceyqRW1StZ207l_xzo_jHMe5dasEvERx4tppvi_2sf2dY0LeCAHdsAoDh6eKOVxo6UiZeo7HNJNumI60EWOefA-PzvnXi-Ci1_vdUi1druQwu77Vr-R_UIVrgCt6yf4DsnWhcAHOAV84AsJw_CuMAzAPT2EsD-_Jq84dNRmvFYpTNIC8BFNytUh1XmBc1mxiArMOppN5cTXJcftkbRkAqXK7vnkxXc-KBUrWMdRxuhjg3L4Rzhm3LXTNRHmRlXIEjilsDUVBfwiWLKpwlwOdq8KGf8UK9VWVmi9wgn9Z2EWknw1ZW6ZxZ9uBzdX_w3EdGKG69AMVoSX3jlvZcjs7Xk85wANAN9haDVPW_y9sqWQa9wOUdnSbcL_FVd5qkMHc9G_tKVzBsafQsyH8eMiHmxnhtc5nhjcCRnhx6ca9EZrb3rlD7rIoKkUCx9_qNSzOzd7B9QNXIUMFP-hWu0vu2ZK6xtGNEc-mcLdlCZ09IHsWJ_qp5OND0tP5I3L_xML0mPwK3p2-_-DhcTsZKZKRAjeoJSNtyEghZchIb5CRGjJ-pEhF2qIiLUa0S0VqqUgbKprqairShopPyPmXz2eHR47dGcTJuGArJ2VCZlxGATQlOsw8BYlwNBJayVgr34dOzHdZGMtRJOOAZ5CRSWh94iwTKgaLf5_s5EWunxLq6YhpP41ZxCTPAjBfAyhXZVIFzPV12idOBUmS2bD5uHvLNDHyDcETADMBMBOeIJh98rbOPy8DxmzN-bpCOIE2Hd8ffBjw_xOcUxGxcLfniAQKqkXcJ_slI-q6LJP6JOpQpb6P4eS7d_LJ2ISVB9sFBjvus21FPie7zQf5guysFpf6JVjkK_nKEP8PM4_qfA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=5%28S%29%2C15%28S%29-dihydroxyeicosatetraenoic+acid+and+lipoxin+generation+in+human+polymorphonuclear+cells%3A+dual+specificity+of+5-lipoxygenase+towards+endogenous+and+exogenous+precursors&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Chavis%2C+C&rft.au=Vachier%2C+I&rft.au=Chanez%2C+P&rft.au=Bousquet%2C+J&rft.date=1996-04-01&rft.issn=0022-1007&rft.volume=183&rft.issue=4&rft.spage=1633&rft_id=info:doi/10.1084%2Fjem.183.4.1633&rft_id=info%3Apmid%2F8666921&rft.externalDocID=8666921
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon